S. Wright

Cognitive and psychiatric symptom trajectories 2-3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK.

L. Wain, K. Rawlik, M. Halling-Brown, 2024, The lancet. Psychiatry.

Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial

J. Graggaber, G. Boehmer, G. Koduri, 2023, The Lancet. Respiratory medicine.